Granulomatous hepatitis after intravesical BCG treatment for bladder cancer.
Artículo
en Inglés
| IMSEAR
| ID: sea-64955
ABSTRACT
Intravesical bacillus Calmette-Guerin (BCG) is used in patients with urinary bladder carcinoma. Although it is generally well tolerated, granulomatous hepatitis is a rare but serious complication. We report a 42-year-old man and a 56-year-old man who developed granulomatous hepatitis following intravesical BCG. One of them was treated successfully with antitubercular therapy; the other died because of BCG sepsis and multi-organ failure.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Tuberculosis Hepática
/
Biopsia con Aguja
/
Neoplasias de la Vejiga Urinaria
/
Administración Intravesical
/
Humanos
/
Masculino
/
Vacuna BCG
/
Carcinoma de Células Transicionales
/
Resultado Fatal
/
Adulto
Idioma:
Inglés
Año:
2006
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS